Dr. Rahul Pratap Singh

Assistant Professor
Pharmaceutics


Professional Biography

Rahul Pratap Singh is an expert in the area of Pharmaceutics with a strong background in fabrication and characterization of pharmaceutical dosage forms using advanced scientific tools. His research focuses on the cancer nanotechnology, protein, peptides and receptor binding, xenograft modeling, multifunctionalized nanomedicines to improve the safety profile of chemotherapeutics and therapeutic outcomes in cancer patients. He has tough pharmaceutics related subjects to under graduate and diploma pharmacy students.

Before joining up GD Goenka University in 2017, Rahul Pratap Singh served as a Junior and Senior Research Fellow at Banaras Hindu University, Varanasi. He also worked in Formulation and Development (F&D) (injectable) as a Research Associate, Mankind Research Centre, Gurugram, India.

Rahul Pratap Singh holds a Ph.D. from the Banaras Hindu University, Varanasi; M. Pharm. and B. Pharm. from the Bundelkhand University, Jhansi.

Publications (from 2015)

Scholarly Journals
‘Transferrin receptor targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery’. International Journal of Biological Macromolecules, 83, pp. 335-344 (Singh, R.P., Sharma, G., Sonali, et al., 2016).

‘Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment’. Colloids and Surfaces B: Biointerfaces, 141, pp. 429-442 (Singh, R.P., Sharma, G., Sonali., 2016).

‘Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.’Drug Delivery, 23(4), pp. 1261-1271. (Sonali, Singh, R.P., Singh, N., 2016).

‘Transition from passive to active targeting of oral insulin nanomedicines: Enhancement in bioavailability and glycemic control in diabetes’, Nanomedicine. 11(11), pp. 1465-1486. (Kaklotar, D., Agrawal, P., Singh, R.P., 2016).

‘Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats’, Drug Delivery, 23(5), pp. 1788-1798. (Sonali, Agrawal, P., Singh, R.P., 2016).

‘Effects of transferrin conjugated multi-walled carbon nanotubes in lung cancer delivery’.’Materials Science and Engineering C. 67, pp. 313-325. (Singh, R.P., Sharma, G., Sonali, 2016).

‘RGD-TPGS decorated theranostic liposomes for brain targeted delivery’. Colloids and Surfaces B: Biointerfaces. 147, pp. 129-141. (Sonali, Singh, R.P., Sharma, G., 2016).

‘Bioadhesive micelles of D-α-tocopherol polyethylene glycol succinate 1000: Synergism of chitosan and transferrin in targeted drug delivery’. Colloids and Surfaces B: Biointerfaces, 152, pp. 277-288. (Agrawal, P., Sonali, Singh, R.P., 2017).

‘TPGS-chitosan cross-linked targeted nanoparticles for effective brain cancer therapy’. Materials Science and Engineering C. 74, pp. 167-176 (Agrawal, P., Singh, R.P., Sonali, 2017).

‘Chitosan-folate decorated carbon nanotubes for site specific lung cancer delivery’. Materials Science and Engineering C. 77, pp. 446-458. (Singh, R.P., Sharma, G., Sonali, 2017).

‘Nanotheranostics: Emerging strategies for early diagnosis and therapy of brain cancer’. Nanotheranostics, 2(1), pp. 70-86. (Sonali, Viswanadh, M.K., Singh, R.P., 2018).

‘Fabrication of a novel drug-resin combination device for controlled releaseof dextromethorphan hydrobromide’. Colloids and Surfaces B: Biointerfaces, 189, p. 110833. (Liu, H., Hua, L., Singh. R.P., 2020).

Research Monographs, Books and Book Chapters

‘Novel drug carriers: Formulation and evaluation of nimesulide loaded microspongic gel for topical pain and inflammation disease treatments’. Lambert Academic Publishing.(Singh, R.P., Prajapati, S.K., Singh, S. 2014).

‘Microsponges for colon drug delivery: Preparation and characterization of prednisolone loaded microsponges’. Lambert Academic Publishing. (Singh, S., Prajapati, S.K., Singh, R.P.,2014).

Current Research

Rahul Pratap has done research focused on development and characterization of biomolecules decorated nanomedicines for cancer treatment and diagnosis simultaneously.

Contribution to the Profession and Awards (from 2015)

Journal Editorship: Current Proteins and Peptides: Bentham Science;

International Research Journal of Pharmacology: Acta Scientific Pharmaceutical Sciences

Reviewer, Journal and Funding Agencies: Department of Science and Technology, India; Science and Engineering Research Board, Funding Agency, India; International Journal of Pharmaceutics (Elsevier); European Journal of Pharmaceutics and Biopharmaceutics (Elsevier)

National Award for Excellence in Research: Gandhian Young Technology Innovation Award 2017 during the Festival of Innovations (FOIN), hosted by The office of the President of India, Rashtrapati Bhavan, New Delhi.

Fellowship: Received Junior Research Fellowship (JRF) from University Grants Commission, New Delhi from April 2012 to March 2013

Received Senior Research Fellowship (SRF) from University Grants Commission, New Delhi from April 2015 to October 2016

Professional Recognitions: Lifetime membership of Association of Pharmaceutical Teachers (APTI) of India, from October 2017

Current Research

Rahul Pratap Singh's current research focuses on synthesis and evaluation of aptamers/peptides targeted theranostic multifunctional nanomedicines for cancer treatment and diagnosis. Recently, he has received a research grant worth Rupees Forty-One Lakh from Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India to conduct research in the area of Cancer Theranostic.